Oscar Health Slips as Investors Await Quarterly Results
The insurer lagged a rising market, while analysts expect higher quarterly revenue and have raised their consensus earnings estimate.
Oscar Health shares fell 3.05% to $29.90 in the latest session, while the S&P 500 rose 0.2%. The Dow and Nasdaq each gained 0.04%.
The stock has risen 1.68% over the past month, according to the article. That outpaced declines of 4.84% in the Finance sector and 0.35% in the S&P 500 over the same period.
Ahead of the company’s upcoming earnings disclosure, Zacks consensus estimates project quarterly earnings of minus $0.11 per share, an increase of 79.25% from the same quarter last year. The revenue estimate is $4.72 billion, up 58.14% year over year.
For the full year, analysts expect earnings of $1.83 per share and revenue of $18.81 billion. Those estimates represent increases of 208.28% and 60.77%, respectively, from last year.
Zacks said its consensus estimate for earnings per share rose 18.79% over the past 30 days. The article did not give a date for Oscar Health’s upcoming earnings disclosure.
This article was produced with the help of AI technology.
Source: Yahoo Finance
